Clinical Trials Update: June 18, 2007
Fibrocystic Breast Disease Obesity Epilepsy (Pediatric)
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Fibrocystic Breast Disease
This study will evaluate an investigational medicated gel to see if it effectively controls breast pain. Women at least 18 with a regular menstrual cycle who have moderate-to-severe pain associated with cyclical fibrocystic breast disease may qualify.
The research site is in Tucson, Ariz.
Volunteers at least 18 who have a body mass index greater than 30 kg/m2 and are generally in good health may be eligible for this study of obesity.
The research site is in Mount Pleasant, S.C.
This study will evaluate open-label levetiracetam treatment in children with partial onset seizures. Pediatric patients with partial onset seizures for whom levetiracetam treatment will be of possible benefit, and who do not have a current diagnosis of Lennox-Gastaut syndrome or epilepsy secondary to a progressing cerebral disease may be included.
The research sites are located worldwide.
Copyright 2007 Thomson CenterWatch. All rights reserved.